JavaScript is disabled in your browser. Please enable JavaScript to view this website.

Enhancing Detection Capabilities in Flow Cytometry through Nanotechnology

Introduction

Flow cytometry is a widely used technique in biomedical research and diagnostics that enables the rapid analysis of individual cells and particles. A flow cytometer consists of five key components: the flow cell, measuring system, detector, amplification system, and a computer for signal analysis. Unlike traditional microscopes that generate images, flow cytometers provide automated, quantitative data on individual cells by measuring their optical properties. These advanced instruments use multiple lasers and fluorescence detectors to analyze cells with high precision.

This article explores how different nanoparticles-such as quantum dots, metallic nanoparticles, magnetic nanoparticles, and biosensors-enhance various components of the flow cytometry system, improving sensitivity, detection accuracy, and overall efficiency in biomedical research and diagnostics.

Types of Nanoparticles in Flow Cytometry

  1. QDs into flow cytometry assays has led to the development of advanced techniques such as quantum dot-encoded microbeads. These microbeads, embedded with specific QDs, serve as distinguishable labels in multiplexed assays, enabling the simultaneous detection of multiple analytes within a single sample. This approach enhances the throughput and accuracy of immunoassays.4,5
  2. QDs' exceptional photostability and brightness have improved the sensitivity of flow cytometric analyses. For instance, a study explores the use of quantum dots (QDs) in bacterial labeling. Researchers investigated the direct conjugation of carboxyl-functionalized QDs with Escherichia coli by leveraging surface-displayed histidine-rich peptides. The method facilitated efficient and specific labeling of the bacteria, demonstrating the potential of QDs for advanced bacterial detection and imaging applications. The thermal stability of QDs ensures consistent fluorescence signals, allowing for precise and reliable measurements.6
  3. Quatitative determination of multiple tumor markers: A study by Chen et al., quantum dots (QDs) were employed as fluorescent labels in flow cytometry to enhance the detection sensitivity of tumor markers. Specifically, QD-labeled antibodies were used to target and identify cancer biomarkers, resulting in improved signal intensity and stability compared to traditional fluorescent dyes. This approach facilitated more precise and reliable detection of tumor cells, demonstrating the potential of QDs in advancing flow cytometric analysis for cancer diagnostics.7
  4. On the downside, quantum dots (QDs) have been utilized to investigate their interactions with RAW264.7 monocyte–macrophage cells. Flow cytometry had been employed to monitor the uptake kinetics and quantify the intracellular accumulation of these nanoparticles over time. The research aimed to assess the impact of QDs on cell viability and function. The findings indicated that the tested nanoparticles were suitable for short-term assays due to their rapid ingestion and accumulation within the cells.8 The study highlights a key limitation of quantum dots (QDs) beyond their known toxicity: their interaction with immune cells, particularly macrophages (RAW264.7 cells), which can lead to altered immune responses. QDs are rapidly sequestered by immune cells, affecting their biodistribution and performance, if they are rapidly cleared by immune cells or cause unintended immune response could compromise their effectiveness as fluorescent probes.

See how Danaher Life Sciences can help

Talk to an Expert

  1. Enhancing Detection Sensitivity: A study found that red-shifted excitation lasers in flow cytometry improved the detection of intracellular gold nanoparticles (AuNPs), allowing precise nanoparticle uptake measurement in live cells, thus enhancing flow cytometric sensitivity9
  2. Fluorescence Signal Enhancement: Research showed that AuNPs conjugated with secondary fluorescent antibodies amplified fluorescence signals at exceptionally low antibody concentrations, making them viable for routine flow cytometry applications10
  3. Label-Free Cell Differentiation: An innovative study used gold nanorods (GNRs) to classify different cell types in flow cytometry by leveraging their scattering properties. This label-free method eliminates the need for fluorescent labeling while maintaining high detection accuracy11
  4. Nanoparticle uptake, aggregation, and cellular interactions in real-time: Additionally, a study presents a flow cytometry-based method to quantify cell-associated silver nanoparticles (AgNPs) in lung cancer cells (A549) by analyzing side scatter (SSC) intensity variations. By correlating SSC signals with AgNP size (40–200 nm), researchers established a quantitative approach to assess the uptake and AgNP-cell interaction . under varying experimental conditions, providing insights into AgNP internalization dynamics,12 for their potential applications in Nanomedicine & Drug Delivery, Cancer Therapy Monitoring, development of biosensors for detecting biomarkers or pathogens by leveraging AgNPs’ unique optical properties.

Biosensors for Real-Time Monitoring: Electrochemical biosensors are innovative devices that detect biochemical reactions between bioreceptors and target molecules, such as enzyme-substrate or antigen-antibody interactions and convert them into electrical signals that can be measured and analyzed. The key advantages of electrochemical biosensors include high sensitivity even at low concentrations, ease of fabrication, reproducibility, and fast analytical time. Nanoparticle-based biosensors have been integrated with flow cytometry to enable real-time, label-free detection of biomarkers. These biosensors utilize nanoparticles that change their optical properties, such as fluorescence or color, upon interaction with specific biomarkers, allowing for immediate analysis without the need for additional labeling steps.

  1. Detection of Extracellular Vesicles (EVs): Nanoparticle-based biosensors have been utilized to detect EVs using flow cytometry. Conventional techniques like nanoparticle tracking analysis and dynamic light scattering are complemented by flow cytometry methods, which offer high-throughput analysis and the ability to detect specific EV subpopulations.14
  2. Multiplexed Detection of Cancer Biomarkers: Nanoparticle-based optical biosensors have been developed for the simultaneous detection of multiple cancer biomarkers. These biosensors utilize the unique optical properties of nanoparticles to achieve high sensitivity and specificity, facilitating early cancer diagnosis through flow cytometric analysis.15
  3. Detection of circulating tumor cells (CTCs): Another unique approach presents an ultrasensitive electrochemical cytosensor designed for the specific capture, quantitative detection, and noninvasive release of EpCAM-positive tumor cells. The biosensor utilizes gold nanoparticles (AuNPs) to modify the electrode, enhancing its performance. Three types of AuNPs with controllable sizes, conjugated with monoclonal anti-EpCAM antibodies, were employed to improve detection sensitivity.16

Principles of Nanotechnology Used in Flow Cytometry and Their Procedures

Flow cytometry relies on five key components: a flow cell, measuring system, detector, amplification system, and a computer for data analysis. Each type of nanoparticle plays a role in improving different stages of this process. Quantum dots (QDs) enhance the measuring system by providing brighter, more stable fluorescence signals, improving biomarker detection. Metallic nanoparticles (gold and silver) boost the detector and amplification system by enhancing fluorescence signals and light scattering, making rare cell detection more precise. Magnetic nanoparticles aid the flow cell phase, enabling efficient cell sorting and isolation using magnetic separation. Biosensors integrate across multiple phases, allowing real-time, label-free detection, reducing the need for additional reagents. Together, these nanoparticles refine flow cytometry, making it more sensitive, efficient, and accurate in analyzing individual cells.By incorporating these nanoparticle technologies, researchers are making flow cytometry more precise, sensitive, and adaptable for a wide range of applications, including cancer diagnostics, infectious disease detection, and regenerative medicine.

1. Quantum Dots (QDs) for Fluorescence Labeling

How it works:
QDs are made from semiconductor materials and dissolved in organic solvent which is then heated to form nanocrystals, whose size depend upon the reaction time and temperature. To make QDs biocompatible, a protective shell (like zinc sulfide) is added, and they are coated with functional groups (e.g., carboxyl or amine) for antibody conjugation. Quantum dots (QDs) used in biological applications, consist of three layers: a cadmium selenide core, a semiconductor shell (e.g., zinc sulfide), and a functionalized polymer coating. Their fluorescence emission depends on shell size, typically ranging from 3-10 nm.2 Unlike traditional fluorescent dyes, QDs offer high-resolution, multicolor detection with minimal background interference. When passed through the flow cytometer, QDs produce strong fluorescence signals, allowing highly accurate detection of different cell types.3

Procedure:

  1. Cells are prepared and suspended in a fluid.
  2. QD-labeled antibodies are added to bind with target biomarkers.
  3. The sample is passed through the flow cytometer, where a laser excites the QDs.
  4. The emitted fluorescence is detected, and each cell is identified based on its fluorescent signal.

See how Danaher Life Sciences can help

Talk to an Expert

2. Metallic Nanoparticles (Gold and Silver) for Signal Enhancement

How It Works:

Procedure:

  1. Gold or silver nanoparticles are attached to specific antibodies that recognize biomarkers.
  2. The sample containing labeled cells is passed through the flow cytometer.
  3. The metallic nanoparticles enhance the fluorescence signal of the bound antibodies.
  4. The cytometer detects the stronger signal, allowing for more precise identification of rare cells.

3. Magnetic Nanoparticles for Cell Sorting and Isolation

How It Works:

Procedure:

  1. Magnetic nanoparticles are coated with antibodies that recognize target cells.
  2. The sample is placed in a column under a strong magnetic field.
  3. Targeted cells with bound magnetic nanoparticles are held in the column, while other cells are washed away.
  4. The magnet is removed, releasing the isolated target cells for further analysis.

4. Biosensors for Real-Time Monitoring

How It Works:

Procedure:

  1. Cells are incubated with biosensor nanoparticles that recognize target molecules.
  2. As cells interact with their surroundings, the biosensors detect changes in biomarker levels.
  3. The sample is analyzed in the flow cytometer, which captures fluorescence or color shifts.
  4. The results provide instant, real-time monitoring of cellular processes.

Conclusion

The use of nanotechnology in flow cytometry has transformed the field by enhancing sensitivity, accuracy, and efficiency. Various nanoparticles like, Quantum dots, metallic nanoparticles, magnetic nanoparticles, and biosensors each play a unique role in improving detection and analysis.

Together, these nanoparticles refine flow cytometry, making it more sensitive, efficient, and accurate in analyzing individual cells. Also, integrating nanotechnology into flow cytometry will lead to better disease diagnosis, personalized medicine, and innovative research breakthroughs.

References:

References

  1. Chan WCW, Nie S. (1998) Quantum Dot Bioconjugates for Ultrasensitive Nonisotopic Detection.  Science  281:2016–8.
  2. Saha A et al. (2013) Near-Unity Quantum Yield in Semiconducting Nanostructures: Structural Understanding Leading to Energy Efficient Applications. J Phys Chem Lett. 4:3544–49.
  3. Ibáñez-Peral R et al. (2008) Potential Use of Quantum Dots in Flow Cytometry. Int J Mol Sci, pp. 2622–2638.
  4. Wang H, Wang Z, Xie F, et al. Multiplex competitive microbead-based flow cytometric immunoassay for simultaneous detection of four chemical residues. Anal Chim Acta. 2013;758:95-101. doi:10.1016/j.aca.2012.10.047.
  5. Yu HW, Kim IS, Niessner R, Knopp D. Multiplex competitive microbead-based flow cytometric immunoassay using quantum dot fluorescent labels. Anal Chim Acta. 2012;750:191-198. doi:10.1016/j.aca.2012.05.017.
  6. Zhang Y, Liu J, Wang Y, et al. Direct conjugation of fluorescent quantum dots with E. coli via surface-displayed histidine-based peptides. Colloids Surf B Biointerfaces. 2021;205:111878. doi:10.1016/j.colsurfb.2021.111878.
  7. Chen X, Zhou W, Liang C, et al. Multiplexed detection of tumor markers with quantum dot-based immunoassays. Sci Rep. 2016;6:33140. doi:10.1038/srep33140.
  8. Gladkovskaya E, Khapchaeva S, Mikhailova M, et al. The interaction of QDs with RAW264.7 cells: Nanoparticle quantification, uptake kinetics, and immune responses study. RSC Adv. 2015;5(42):32317-32324. doi:10.1039/C5RA04233J
  9. Wu Y, Ali MRK, Dansby K, El-Sayed MA. Improving the flow cytometry-based detection of the cellular uptake of gold nanoparticles. Anal Chem. 2019;91(22):14261-14267. doi:10.1021/acs.analchem.9b02248.
  10. 5.Reis DS, de Oliveira VL, Silva ML, et al. Gold nanoparticles enhance fluorescence signals by flow cytometry at low antibody concentrations. J Mater Chem B. 2021;9(3):692-702.doi:10.1039/D0TB02309D
  11. Chakraborty R, Leshem-Lev D, Kornowski R, Fixler D. The scattering of gold nanorods combined with differential uptake, paving a new detection method for macrophage subtypes using flow cytometry. Nano Lett. 2020;20(12):8745-8752. doi:10.1021/acs.nanolett.0c03525.
  12. Zhao X, Hwang SH, Zhou J, et al. Quantitative estimation of cell-associated silver nanoparticles using the normalized side scattering intensities of flow cytometry. Nanomaterials (Basel). 2021;11(12):3223. doi:10.3390/nano11123223.
  13. Shen MJ, Olsthoorn RCL, Zeng Y, Bakkum T, Kros A, Boyle AL. Magnetic-activated cell sorting using coiled-coil peptides: An alternative strategy for isolating cells with high efficiency and specificity. ACS Appl Mater Interfaces. 2021;13(10):11621-11630. doi:10.1021/acsami.0c22185.
  14. Martín-Gracia B, Martín-Barreiro A, Cuestas-Ayllón C, et al. Nanoparticle-based biosensors for detection of extracellular vesicles in liquid biopsies. J Mater Chem B. 2020;8(25):5526-5539. doi:10.1039/D0TB00861C.
  15. Amri C, Shukla AK, Lee JH. Recent Advancements in Nanoparticle-Based Optical Biosensors for Circulating Cancer Biomarkers. Materials (Basel). 2021 Mar 10;14(6):1339. doi: 10.3390/ma14061339. PMID: 33802028; PMCID: PMC8001438.
  16. Zhu Y, Chandra Y, Liu Y, et al. Multifunctional gold nano-cytosensor with quick capture, specific recognition, high sensitivity for detection, and noninvasive release of circulating tumor cells. Front Bioeng Biotechnol. 2021;9:783661. doi:10.3389/fbioe.2021.783661.